DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 3Dr. Reddy's Laboratories
02 1Biocon
03 2MSN Laboratories
04 1Natco Pharma
05 2Sichuan Elixir Pharmaceuticals
06 1Sun Pharmaceutical Industries Limited
Reset all filters
01 3CABOZANTINIB (S)-MALATE
02 1CABOZANTINIB (S)-MALATE (FORM N-2)
03 1CABOZANTINIB (S)-MALATE (FORM-S)
04 1CABOZANTINIB HYDROCHLORIDE
05 1CABOZANTINIB INTERMEDIATE (CZT3)
06 1CABOZANTINIB SULFATE
07 1CABOZANTINIB-(S)-MALATE
08 1CABOZANTINIB-S-MALATE
Reset all filters
01 2China
02 8India
Reset all filters
01 10Active
Reset all filters
01 5Complete
02 5Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38207
Submission : 2023-03-31
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39141
Submission : 2023-12-01
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39274
Submission : 2023-12-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-12-06
Pay. Date : 2023-03-08
DMF Number : 38057
Submission : 2023-09-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-06-25
Pay. Date : 2019-04-22
DMF Number : 33137
Submission : 2018-09-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-06-08
Pay. Date : 2017-05-22
DMF Number : 31522
Submission : 2017-03-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-03-23
Pay. Date : 2022-02-28
DMF Number : 36509
Submission : 2022-02-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39785
Submission : 2024-03-26
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39757
Submission : 2024-03-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-12-17
Pay. Date : 2019-10-11
DMF Number : 34201
Submission : 2019-11-06
Status : Active
Type : II
53
PharmaCompass offers a list of Cabozantinib S-Malate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cabozantinib S-Malate manufacturer or Cabozantinib S-Malate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cabozantinib S-Malate manufacturer or Cabozantinib S-Malate supplier.
PharmaCompass also assists you with knowing the Cabozantinib S-Malate API Price utilized in the formulation of products. Cabozantinib S-Malate API Price is not always fixed or binding as the Cabozantinib S-Malate Price is obtained through a variety of data sources. The Cabozantinib S-Malate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A cabozantinib (S)-malate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of cabozantinib (S)-malate, including repackagers and relabelers. The FDA regulates cabozantinib (S)-malate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. cabozantinib (S)-malate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of cabozantinib (S)-malate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A cabozantinib (S)-malate supplier is an individual or a company that provides cabozantinib (S)-malate active pharmaceutical ingredient (API) or cabozantinib (S)-malate finished formulations upon request. The cabozantinib (S)-malate suppliers may include cabozantinib (S)-malate API manufacturers, exporters, distributors and traders.
click here to find a list of cabozantinib (S)-malate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A cabozantinib (S)-malate DMF (Drug Master File) is a document detailing the whole manufacturing process of cabozantinib (S)-malate active pharmaceutical ingredient (API) in detail. Different forms of cabozantinib (S)-malate DMFs exist exist since differing nations have different regulations, such as cabozantinib (S)-malate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A cabozantinib (S)-malate DMF submitted to regulatory agencies in the US is known as a USDMF. cabozantinib (S)-malate USDMF includes data on cabozantinib (S)-malate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The cabozantinib (S)-malate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of cabozantinib (S)-malate suppliers with USDMF on PharmaCompass.
We have 6 companies offering cabozantinib (S)-malate
Get in contact with the supplier of your choice: